TMB Capital Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$492K Sell
410
-2
-0.5% -$2.04K 0.15% 111
2026
Q1
$379K Sell
412
-13
-3% -$13.2K 0.13% 125
2025
Q4
$456K Buy
+425
New +$406K 0.16% 108

Other funds holding LLY

TMB Capital Partners's LLY Position: Q2 2026 in Review

TMB Capital Partners reduced its Eli Lilly (LLY) stake by 0.49% in Q2 2026, selling an estimated $2.04K and leaving 410 shares worth $492K. The position accounts for 0.15% of the portfolio, ranked #111.

TMB Capital Partners first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,613 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • TMB Capital Partners held 410 shares of Eli Lilly worth $492K as of Q2 2026.
  • TMB Capital Partners sold 2 Eli Lilly shares in Q2 2026, an estimated $2.04K.
  • Eli Lilly made up 0.15% of TMB Capital Partners's portfolio in Q2 2026, its #111 holding.
  • TMB Capital Partners first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,613 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on TMB Capital Partners's 13F filing for Q2 2026, filed 24 Jul 2026.